XML 20 R9.htm IDEA: XBRL DOCUMENT v3.19.2
Net Income per Common Share Attributable to Magellan Health, Inc.
6 Months Ended
Jun. 30, 2019
Net Income per Common Share Attributable to Magellan Health, Inc.

NOTE B—Net Income per Common Share Attributable to Magellan Health, Inc.

The following table reconciles income attributable to common shareholders (numerator) and shares (denominator) used in the computations of net income per share attributable to common shareholders (in thousands, except per share data) for the three and six months ended June 30:

Three Months Ended

Six Months Ended

June 30, 

June 30, 

    

2018

    

2019

    

2018

    

2019

    

Numerator:

Net income

$

13,551

$

13,613

$

25,003

$

14,044

Denominator:

Weighted average number of common shares outstanding—basic

 

24,569

 

24,101

 

24,460

 

24,024

Common stock equivalents—stock options

 

669

 

153

 

738

 

132

Common stock equivalents—RSAs

 

33

 

7

 

28

 

7

Common stock equivalents—RSUs

 

23

 

18

 

50

 

19

Common stock equivalents—PSUs

111

130

232

127

Common stock equivalents—employee stock purchase plan

 

2

 

7

 

2

 

6

Weighted average number of common shares outstanding—diluted

 

25,407

 

24,416

 

25,510

 

24,315

Net income per common share—basic

$

0.55

$

0.56

$

1.02

$

0.58

Net income per common share—diluted

$

0.53

$

0.56

$

0.98

$

0.58

The weighted average number of common shares outstanding for the three and six months ended June 30, 2018 and 2019 were calculated using outstanding shares of the Company’s common stock. Common stock equivalents included in the calculation of diluted weighted average common shares outstanding for the three and six months ended June 30, 2018 and 2019 represent stock options to purchase shares of the Company’s common stock, RSAs, RSUs, PSUs and stock purchased under the Employee Stock Purchase Plan.

The Company had additional potential dilutive securities outstanding representing 0.5 million and 0.3 million options for the three and six months ended June 30, 2018, respectively, and 1.1 million and 1.1 million options for the three and six months ended June 30, 2019, respectively, that were not included in the computation of dilutive securities because they were anti-dilutive for the period. Had these shares not been anti-dilutive, all of these shares would not have been included in the net income attributable to common shareholder per common share calculation as the Company uses the treasury stock method of calculating diluted shares.